(Q53236896)

English

Incidence of invasive pneumococcal disease among individuals with sickle cell disease before and after the introduction of the pneumococcal conjugate vaccine.

scientific article published on 18 April 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/17479937

Incidence of invasive pneumococcal disease among individuals with sickle cell disease before and after the introduction of the pneumococcal conjugate vaccine. (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/17479937

sickle-cell disease

0 references

1 reference

based on heuristic

inferred from title

pneumococcal conjugate vaccine

1 reference

based on heuristic

inferred from title

William Schaffner

7

object named as

William Schaffner

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

Natasha B. Halasa

1

object named as

Natasha B Halasa

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/17479937

Marie R. Griffin

9

object named as

Marie R Griffin

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/17479937

author name string

Sadhna M Shankar

2

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/17479937

Thomas R Talbot

3

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/17479937

Patrick G Arbogast

4

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/17479937

Ed F Mitchel

5

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/17479937

Winfred C Wang

6

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/17479937

Allen S Craig

8

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/17479937

language of work or name

0 references

publication date

18 April 2007

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/17479937

Clinical Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/17479937

44

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/17479937

11

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/17479937

1428-1433

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/17479937

Safety and immunogenicity of heptavalent pneumococcal vaccine conjugated to CRM(197) among infants with sickle cell disease. Pneumococcal Conjugate Vaccine Study Group

1 reference

https://api.crossref.org/works/10.1086%2F516781

21 January 2018

Infection Caused by Streptococcus pneumoniae in Children with Sickle Cell Disease: Epidemiology, Immunologic Mechanisms, Prophylaxis, and Vaccination

1 reference

https://api.crossref.org/works/10.1086%2F516781

21 January 2018

Pneumococcal vaccine in the United States. A critical analysis

1 reference

https://api.crossref.org/works/10.1086%2F516781

21 January 2018

Failure of Pneumococcal Vaccine in Children with Sickle-Cell Disease

1 reference

https://api.crossref.org/works/10.1086%2F516781

21 January 2018

Penicillin- and cephalosporin-resistant strains of Streptococcus pneumoniae causing sepsis and meningitis in children with sickle cell disease

1 reference

https://api.crossref.org/works/10.1086%2F516781

21 January 2018

Discontinuing penicillin prophylaxis in children with sickle cell anemia. Prophylactic Penicillin Study II.

1 reference

https://api.crossref.org/works/10.1086%2F516781

21 January 2018

Prediction of adverse outcomes in children with sickle cell disease

1 reference

https://api.crossref.org/works/10.1086%2F516781

21 January 2018

Survival of children with sickle cell disease

1 reference

https://api.crossref.org/works/10.1086%2F516781

21 January 2018

Outcome of sickle cell anemia: a 4-decade observational study of 1056 patients

1 reference

https://api.crossref.org/works/10.1086%2F516781

21 January 2018

The safety of 7-valent pneumococcal conjugate vaccine

1 reference

https://api.crossref.org/works/10.1086%2F516781

21 January 2018

Policy Statement: Recommendations for the Prevention of Pneumococcal Infections, Including the Use of Pneumococcal Conjugate Vaccine (Prevnar), Pneumococcal Polysaccharide Vaccine, and Antibiotic Prophylaxis

1 reference

https://api.crossref.org/works/10.1086%2F516781

21 January 2018

Impact of childhood vaccination on racial disparities in invasive Streptococcus pneumoniae infections

1 reference

https://api.crossref.org/works/10.1086%2F516781

21 January 2018

Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine

1 reference

https://api.crossref.org/works/10.1086%2F516781

21 January 2018

Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine

1 reference

https://api.crossref.org/works/10.1086%2F516781

21 January 2018

Elimination of racial differences in invasive pneumococcal disease in young children after introduction of the conjugate pneumococcal vaccine.

1 reference

https://api.crossref.org/works/10.1086%2F516781

21 January 2018

Oral corticosteroid use among children in TennCare

1 reference

https://api.crossref.org/works/10.1086%2F516781

21 January 2018

Provision of pneumococcal prophylaxis for publicly insured children with sickle cell disease

1 reference

https://api.crossref.org/works/10.1086%2F516781

21 January 2018

Medical care utilization and mortality in sickle cell disease: a population-based study.

1 reference

https://api.crossref.org/works/10.1086%2F516781

21 January 2018

Use of surveillance for invasive pneumococcal disease to estimate the size of the immunosuppressed HIV-infected population

1 reference

https://api.crossref.org/works/10.1086%2F516781

21 January 2018

Active bacterial core surveillance of the emerging infections program network

1 reference

https://api.crossref.org/works/10.1086%2F516781

21 January 2018

Pneumococcal Meningitis in Sickle-Cell Anemia

1 reference

https://api.crossref.org/works/10.1086%2F516781

21 January 2018

Bacteremia in sickle hemoglobinopathies.

1 reference

https://api.crossref.org/works/10.1086%2F516781

21 January 2018

Invasive pneumococcal infections in children with sickle cell disease in the era of penicillin prophylaxis, antibiotic resistance, and 23-valent pneumococcal polysaccharide vaccination.

1 reference

https://api.crossref.org/works/10.1086%2F516781

21 January 2018

Identifiers

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/17479937

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/17479937

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53236896&oldid=2102212000"